Richard Copin
Regeneron (United States)(US)New York University(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Antimicrobial Resistance in Staphylococcus, vaccines and immunoinformatics approaches, Bacterial biofilms and quorum sensing, Bacterial Identification and Susceptibility Testing
Most-Cited Works
- → Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies(2020)1,467 cited
- → REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters(2020)583 cited
- → The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies(2021)235 cited
- → Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets(2020)207 cited
- → M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic Variation and Identifies Rare Variable TB Antigens(2015)148 cited
- → MyD88-Dependent Activation of B220−CD11b+LY-6C+ Dendritic Cells during Brucella melitensis Infection(2007)137 cited
- → Sequence Diversity in the pe_pgrs Genes of Mycobacterium tuberculosis Is Independent of Human T Cell Recognition(2014)91 cited
- → The purine biosynthesis regulator PurR moonlights as a virulence regulator in Staphylococcus aureus(2019)85 cited
- → In Situ Microscopy Analysis Reveals Local Innate Immune Response Developed around Brucella Infected Cells in Resistant and Susceptible Mice(2012)81 cited
- → Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus(2019)80 cited